Suppr超能文献

吸入一氧化氮。绵羊体内肝素-鱼精蛋白血管收缩的一种选择性肺血管扩张剂。

Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep.

作者信息

Fratacci M D, Frostell C G, Chen T Y, Wain J C, Robinson D R, Zapol W M

机构信息

Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston 02114.

出版信息

Anesthesiology. 1991 Dec;75(6):990-9. doi: 10.1097/00000542-199112000-00011.

Abstract

Nitric oxide (NO) has recently been discovered to be an important endothelium-derived relaxing factor and produces profound relaxation of vascular smooth muscle. To learn if NO could be a potent and selective pulmonary vasodilator, NO was inhaled by 16 awake lambs in an attempt to reduce the increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) induced by either the infusion of an exogenous pulmonary vasoconstrictor (the thromboxane analog U46619) or the endogenous release of thromboxane that occurs during the neutralization of heparin anticoagulation by protamine sulfate. Inhaling greater than or equal to 40 ppm of NO during a continuous U46619 infusion returned the PAP to a normal value, without affecting systemic blood pressure or vascular resistance. Pretreatment with the cyclooxygenase inhibitor indomethacin before infusing U46619 did not reduce the pulmonary vasodilatory effect of inhaled NO, and we conclude that the dilatory effect of NO on the lung's circulation is independent of cyclooxygenase products such as prostacyclin. Continuously inhaling NO at 180 ppm did not significantly reduce the mean peak thromboxane B2 concentration at 1 min after protamine injection; however, the mean values of pulmonary hypertension and vasoconstriction at 1 min were markedly reduced below the levels in untreated heparin-protamine reactions. Breathing NO at lower concentrations (40-80 ppm) did not decrease the mean peak PAP and PVR at 1 min after protamine but decreased the PAP and PVR values at 2, 3, and 5 min below those of control heparin-protamine reactions. Intravenous infusion of nitroprusside completely prevented the transient increase of PAP and PVR during the heparin-protamine reaction; however, marked concomitant systemic vasodilation occurred. Inhaled NO is a selective pulmonary vasodilator that can prevent thromboxane-induced pulmonary hypertension during the heparin-protamine reaction in lambs and can do so without causing systemic vasodilation.

摘要

一氧化氮(NO)最近被发现是一种重要的内皮源性舒张因子,可使血管平滑肌产生显著舒张。为了了解NO是否可能是一种强效且选择性的肺血管扩张剂,对16只清醒的羔羊吸入NO,试图降低因输注外源性肺血管收缩剂(血栓素类似物U46619)或硫酸鱼精蛋白中和肝素抗凝过程中内源性血栓素释放所诱导的肺动脉压(PAP)升高和肺血管阻力(PVR)升高。在持续输注U46619期间吸入≥40 ppm的NO可使PAP恢复至正常水平,而不影响体循环血压或血管阻力。在输注U46619之前用环氧化酶抑制剂吲哚美辛预处理并未降低吸入NO的肺血管舒张作用,我们得出结论,NO对肺循环的舒张作用独立于诸如前列环素等环氧化酶产物。在鱼精蛋白注射后1分钟持续吸入180 ppm的NO并未显著降低平均血栓素B2峰值浓度;然而,1分钟时的肺动脉高压和血管收缩平均值明显低于未治疗的肝素-鱼精蛋白反应中的水平。在较低浓度(40 - 80 ppm)下吸入NO在鱼精蛋白注射后1分钟并未降低平均PAP峰值和PVR,但在2、3和5分钟时降低了PAP和PVR值,低于对照肝素-鱼精蛋白反应的值。静脉输注硝普钠可完全预防肝素-鱼精蛋白反应期间PAP和PVR的短暂升高;然而,同时出现了明显的体循环血管舒张。吸入NO是一种选择性肺血管扩张剂,可在羔羊的肝素-鱼精蛋白反应期间预防血栓素诱导的肺动脉高压,且不会引起体循环血管舒张。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验